首页 | 官方网站   微博 | 高级检索  
     

分期辨治加血栓通离子导入治疗视网膜静脉阻塞50例临床观察
引用本文:江志华,谢芳,林小华,苏汉权,陈志祥.分期辨治加血栓通离子导入治疗视网膜静脉阻塞50例临床观察[J].中医临床研究,2014(16):98-99.
作者姓名:江志华  谢芳  林小华  苏汉权  陈志祥
作者单位:四会市中医院;
摘    要:目的:观察中医分期辨证论治加血栓通离子导入治疗视网膜静脉阻塞50例临床疗效。方法:治疗组选用分期辨证论治加血栓通离子导入,联合丹参川芎嗪注射液静滴治疗;对照组单纯使用丹参川芎嗪注射液静滴。观察患者治疗前后视力、眼底体征、FFA相关指标及整体疗效。结果:治疗后两组能提高视力、减轻视网膜出血水肿、改善视网膜循环,且治疗组优于对照组,治疗组与对照组的有效率分别为96%和68%,两组相比具有显著差异(P〈0.05)。结论:中医分期辨证论治加血栓通离子导入治疗视网膜静脉阻塞疗效显著。

关 键 词:分期辨证论治  视网膜静脉阻塞  疗效

Clinical observation on treating 50 cases of retinal vein occlusion in TCM differentiation plus Xueshuan Tong
Abstract:Objective:To observe clinical efficacy of TCM differentiation plus Xueshuan Tong for retinal vein occlusion. Methods:100 patients were randomly divided into control group, given Danshen Chuanxiongqin injection; treated group was given TCM differentiation plus Xueshuan Tong more. Observing visual acuity, fundus signs, FFA index and overall efficacy before and after treatment. Results: 2 therapies both can improve vision acuity and retinal circulation, reduce the retinal hemorrhage and edema; treated group was better than the control. The total efficacy in two groups was 96%and 68%, there was a significant difference (P〈0.05). Conclusion:TCM differentiation plus Xueshuantong were good at treating retinal vein occlusion.
Keywords:TCM differentiation  Retinal vein occlusion  Efficacy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号